Eon Labs Relocates Corporate Headquarters

    Pharmaceutical Writers/Business Editors

    LAKE SUCCESS, N.Y.--(BUSINESS WIRE)--Jan. 20, 2005--Eon Labs, Inc. (Nasdaq: ELAB) announced today the relocation of its Corporate Headquarters to Lake Success, New York.
    The relocation accommodates the Company's growth and places Eon Labs in close proximity to New York City as well as both major New York area airports. This convenient location is close to Eon Labs' Laurelton, New York manufacturing facility and is easily accessible for employees, customers and other visitors.
    Starting today, Eon Labs is operating from its new offices. The new contact information is:

Eon Labs, Inc. 1999 Marcus Avenue Lake Success, NY 11042

Telephone: 516-478-9700 Fax: 516-478-9810

    Eon Labs is a generic pharmaceutical company specializing in developing, licensing, manufacturing, selling and distributing a broad range of prescription pharmaceutical products. For press releases and other company information, visit the Eon Labs, Inc. website at www.eonlabs.com.

    Safe Harbor Statement under the U.S. Private Securities Litigation Reform Act of 1995: This release contains statements that are forward-looking in nature which express the beliefs and expectations of management. Such statements are based on current plans, estimates and expectations and involve a number of known and unknown risks, uncertainties and other factors that could cause the Company's future results, performance or achievements to differ significantly from the results, performance or achievements expressed or implied by such forward-looking statements. These factors and additional information are discussed in the Company's filings with the Securities and Exchange Commission and statements in this release should be evaluated in light of these important factors. Although we believe that these statements are based upon reasonable assumptions, we cannot guarantee future results. Forward-looking statements speak only as of the date on which they are made, and the Company undertakes no obligation to update publicly or revise any forward-looking statement, whether as a result of new information, future developments or otherwise.

--30--ML/ny*

CONTACT: Eon Labs, Inc. Christopher LoSardo, 516-478-9712

KEYWORD: NEW YORK INDUSTRY KEYWORD: PHARMACEUTICAL PRODUCT SOURCE: Eon Labs, Inc.

Copyright Business Wire 2005